Intended for healthcare professionals

Letters Aspirin in primary prevention

Evidence is lacking

BMJ 2010; 340 doi: (Published 26 March 2010) Cite this as: BMJ 2010;340:c1613
  1. Peter D Burrill, specialist pharmaceutical adviser for public health
  1. 1NHS Derbyshire County, Chesterfield S41 7PF
  1. peter.burrill{at}

    Sever states: “The evidence supports such use in those with an estimated 10 year risk of a cardiovascular event of >20%.”1 I am not aware of any prospective, placebo controlled randomised controlled trial (RCT) designed to test this hypothesis. A recent British Hypertension Society publication references a subgroup analysis of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription